Novel osteoanabolic strategies are highly desired to treat osteoporotic bone loss or augment fracture repair in patients at risk of healing complications, including individuals with osteoporosis or inflammatory disorders. Whereas current osteoanabolics address osteoblast function, research by Ren Xu and colleagues highlights the skeletal endothelium as a promising target to promote bone formation.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wright, N. C. et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J. Bone Miner. Res. 29, 2520–2526 (2014).
Baron, R. & Hesse, E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J. Clin. Endocrinol. Metab. 97, 311–325 (2012).
Claes, L., Recknagel, S. & Ignatius, A. Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 8, 133–143 (2012).
Oryan, A., Alidadi, S., Moshiri, A. & Bigham-Sadegh, A. Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations. Biofactors 40, 459–481 (2014).
Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323–328 (2014).
Kusumbe, A. P. et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature 532, 380–384 (2016).
Ramasamy, S. K., Kusumbe, A. P., Wang, L. & Adams, R. H. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376–380 (2014).
Xu, R. et al. Targeting skeletal endothelium to ameliorate bone loss. Nat. Med. 24, 823–833 (2018).
Jones, D. C. et al. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223–1227 (2006).
Shim, J. H. et al. Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts. J. Clin. Invest. 123, 4010–4022 (2013).
Acknowledgements
A.I. and J.T. receive funding from the German Research Foundation (Collaborative Research Center CRC1149, A.I.: INST 40/491-1, J.T.: INST 40/492-1).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ignatius, A., Tuckermann, J. New horizons for osteoanabolic treatment?. Nat Rev Endocrinol 14, 508–509 (2018). https://doi.org/10.1038/s41574-018-0069-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-018-0069-2
This article is cited by
-
The endothelium–bone axis in development, homeostasis and bone and joint disease
Nature Reviews Rheumatology (2021)